Phage-Borne Depolymerases Decrease Klebsiella pneumoniae Resistance to Innate Defense Mechanisms
Деполимеразы, переносимые фагами, снижают устойчивость Klebsiella pneumoniae к механизмам врожденной защиты
2018-10-23
SCID: 54.1/6m6nktat
Discuss with AI
Klebsiella pneumoniaebacteriophage KP32capsule depolymerasescomplement-mediated killingphagocytosis
Figures from the paper
Abstract (AI)
Klebsiella pneumoniae produces capsular polysaccharides that are a crucial virulence factor protecting bacteria against innate response mechanisms of the infected host. Simultaneously, those capsules are targeted by specific bacteriophages equipped with virion-associated depolymerases able to recognize and degrade these polysaccharides. We show that Klebsiella phage KP32 produces two capsule depolymerases, KP32gp37 and KP32gp38, with a high specificity for the capsular serotypes K3 and K21, respectively. Together, they determine the host spectrum of bacteriophage KP32, which is limited to strains with serotype K3 and K21. Both depolymerases form a trimeric β-structure, display moderate thermostability and function optimally under neutral to alkaline conditions. We show that both depolymerases strongly affect the virulence of K. pneumoniae with the corresponding K3 and K21 capsular serotypes. Capsule degradation renders the otherwise serum-resistant cells more prone to complement-mediated killing with up to two log reduction in serum upon exposure to KP32gp37. Decapsulated strains are also sensitized for phagocytosis with a two-fold increased uptake. In addition, the intracellular survival of phagocytized cells in macrophages was significantly reduced when bacteria were previously exposed to the capsule depolymerases. Finally, depolymerase application considerably increases the lifespan of Galleria melonella larvae infected with K. pneumoniae in a time- and strain-dependent manner. In sum, capsule depolymerases are promising antivirulence compounds that act by defeating a major resistance mechanism of K. pneumoniae against the innate immunity.
Key Findings
1
Both enzymes form trimeric β-structures, show moderate thermostability, and function optimally under neutral-to-alkaline conditions.
2
Capsule degradation increases complement-mediated killing by up to two log reductions in serum and doubles phagocytic uptake of K. pneumoniae.
3
Depolymerase treatment reduces intracellular survival in macrophages and substantially prolongs survival of infected Galleria mellonella larvae in a time- and strain-dependent manner.
4
Klebsiella phage KP32 produces two capsule depolymerases, KP32gp37 and KP32gp38, specifically targeting K3 and K21 capsular serotypes.
5
Phage-borne capsule depolymerases are promising antivirulence agents because they overcome capsule-mediated resistance to innate immunity.
6
The two depolymerases determine KP32 host specificity, restricting infection to K. pneumoniae strains carrying K3 or K21 capsules.
Research Object
Klebsiella pneumoniae with K3 and K21 capsular serotypes and its phage-borne capsule depolymerases KP32gp37 and KP32gp38
Research Subject
The effects of capsule depolymerase-mediated decapsulation on innate immune susceptibility, virulence, and host survival
Publication Details
Publication Date
2018-10-23
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest